Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > Big Pharma Is Missing the Nanotechnology Opportunity

February 15th, 2005

Big Pharma Is Missing the Nanotechnology Opportunity

The U.S. National Institutes of Health counts nanomedicine as one of its top five priorities, the National Cancer Institute committed $144 million to nanotechnology research in October 2004, and 40% of nanotech venture capital since 1998 has gone to life sciences start-ups. Yet despite nanotechnology's promise in improving how drugs are developed and delivered, major pharmaceutical companies are committing almost
no money or people to nanotechnology research -- exposing them to strategic
risks, according to a new report from Lux Research entitled "Why Big Pharma Is
Missing the Nanotech Opportunity."


Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Extracellular vesicles could be personalized drug delivery vehicles March 15th, 2018

Department of Materials Test Engineering (WPT) at TU Dortmund University uses Deben CT5000TEC stage to perform X-ray micro-tomography experiments for better understanding of damage progression in composite materials March 13th, 2018

Scientists Use Nanotechnology to Detect Molecular Biomarker for Osteoarthritis March 13th, 2018

Polymer nanoparticle shows ability to locate and treat breast tumors March 13th, 2018

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project